Developing an optimized protocol to measure mitochondrial phenotypes as a blood‐based biomarker for mitochondrial dysfunction in AD

Alzheimers Dement · 2024 · PMC11713115

Europe PMC

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

marginally significantp = 0.058so close (0.05 < p ≤ 0.1)

Result We found that mtDNAcn was lower in EOAD compared to controls, and our results were marginally significant (b [SE] = 127 [51.9], p = 0.058; Figure 1A).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.